Astellas Pharma Inc. (TYO:4503)
1,442.00
+2.50 (0.17%)
Jul 15, 2025, 3:30 PM JST
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of 2.58 trillion as of July 15, 2025. Its market cap has decreased by -4.17% in one year.
Market Cap
2.58T
Enterprise Value
3.33T
Revenue
1.91T
Ranking
n/a
PE Ratio
51.06
Stock Price
1,442.00
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 2.58T, an increase of 192.42%. That is a compound annual growth rate of 3.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 14, 2025 | 2,577.15B | -6.18% |
Dec 30, 2024 | 2,746.92B | -9.13% |
Dec 29, 2023 | 3,022.77B | -17.34% |
Dec 30, 2022 | 3,657.07B | 5.52% |
Dec 30, 2021 | 3,465.82B | 17.06% |
Dec 30, 2020 | 2,960.81B | -15.46% |
Dec 30, 2019 | Pro | Pro |
Dec 28, 2018 | Pro | Pro |
Dec 29, 2017 | Pro | Pro |
Dec 30, 2016 | Pro | Pro |
Dec 30, 2015 | Pro | Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 11.33T |
Takeda Pharmaceutical Company | 6,886.49B |
Daiichi Sankyo Company | 6,365.29B |
HOYA Corporation | 6,227.92B |
Terumo | 3,601.83B |
Otsuka Holdings | 3,478.27B |
Shionogi & | 2,116.08B |
Olympus | 1,889.09B |